| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099993 | Journal of Crohn's and Colitis | 2013 | 8 Pages |
Abstract
This trial provides first evidence of clinical efficacy of vidofludimus in IBD. Although the safety and tolerability profile seems favorable, long-term controlled studies are needed to further investigate its potential as novel IBD therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
K.R. Herrlinger, M. Diculescu, K. Fellermann, H. Hartmann, S. Howaldt, R. Nikolov, A. Petrov, W. Reindl, J.M. Otte, S. Stoynov, U. Strauch, A. Sturm, R. Voiosu, A. Ammendola, B. Dietrich, B. Hentsch, E.F. Stange,